The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.

The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.

The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.

When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.

Share:
More In Business
Beyond Meat Revenue Falls
Beyond Meat reported that it failed to meet market expectations during its quarterly revenue report, as the company has faced weakening demand for its plant-based meat products.
Ready 4 Work Profiles Woman Returning to Workforce
Finding a new job is an emotional journey in itself and one woman is looking to get back into the workforce after some time off. Cheddar News' docuseries Ready 4 Work profiles her as she works through her job search.
Load More